Joe said early on in the call that the two NGIO S-1 received no comments in their review from the SEC, but that they would need to be updated with the latest 10K. So an S-1A will need to be sent in with that change for those 2 S-1's before EFFECT.
Joe stated that as there were no comments from their reviewed, he would essentially be able to pick the effect date for those 2.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links